Cannara Biotech8CB0 
$0.44-5.66%24h
-5.66%24h
Global rank26472
Market cap$39.70M
Change 7d0.00%
YTD Performance-27.93%
SP500 benchmarkUnderperform
P/E5.56
P/S0.94
Revenue$42.06M
Earnings$5.10M
Dividend yield-
Main Sector
Healthcare
Cannara Biotech (8CB0) Total Liabilities
8CB0 Total Liabilities in 2022: $45.38M
According to Cannara Biotech latest financial reports the total liabilities of 8CB0 is $45.38M, an increase of 4.92% to 2022. At the end of 2022 company had $43.25M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Cannara Biotech is responsible for during its operational activities.
Cannara Biotech (8CB0) Total Liabilities History from 2023 to 2022
-
Value:-
8CB0 Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $45.38M | 4.92% |
| 2022 | $43.25M | 110.99% |
| 2021 | $20.50M | 69.28% |
| 2020 | $12.11M | -9.29% |
| 2019 | $13.35M | - |
View the Top Total Liabilies Stocks
